Traditional models often fail to capture the complexity of human biology — slowing drug discovery and limiting predictive accuracy.

Discover how the ImageXpress® HCS.ai High-Content Screening System combines advanced confocal imaging with AI-powered analysis tools to deliver faster acquisition, superior image quality, and deeper phenotypic insights from complex 3D organoid assays.

Key highlights include:

• Over 4.5x improvement in signal-to-noise ratio for thick 3D samples
• Intelligent QuickID™ Targeted Acquisition for faster high-resolution imaging
• AI-enabled segmentation and classification for accurate phenotypic analysis
• Quantification of dose-dependent responses in patient-derived organoids

See how researchers are generating scalable, reproducible, multiparametric data from advanced 3D models while accelerating drug screening workflows.